Safety and efficacy of secondary prophylactic in Patients with severe hemophilia type A and B: A Systematic review and meta-analysis study

Context: Patients with hemophilia recieves coagulation factor replacement for lifetime. In iran, on-demand treatment method is used as standard. Clinical studies have shown significant improvements in clinical and economic outcomes as a result of the use of prophylaxis compared with other therapies....

Full description

Bibliographic Details
Main Authors: Reza Goudarzi, Shirin Seraji, Mohammadreza Amiresmaili, Hasan Gharibnavaz
Format: Article
Language:English
Published: Tehran University of Medical Sciences 2020-05-01
Series:Health Technology Assessment in Action
Subjects:
Online Access:https://htainaction.tums.ac.ir/index.php/hta/article/view/1